RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > FDA Requirements Block Effective Treatment

Source:

Mises Economics Blog

Language:

English

Domain:

blog.mises.org

Search mises.org:

FDA Requirements Block Effective Treatment

14th Nov 2006, 19:39 GMT

The Wall Street Journal reported yesterday (Monday, Nov. 13, front page) on a doctor's frustrations with a company that refuses to sell in the U.S. what he believes is a very effective treatment for infants with short bowel syndrome. The treatment is a new formula called Omegaven, based on fish oil, which does not appear to have the negative effects on the liver that other formulas have. The headline in the WSJ implicates the manufacturer, but the text reveals a reason for the company's reluctance: expensive FDA red tape.

View full story at blog.mises.org

FDA Requirements Block Effective Treatment related news:

Latest news from Mises Economics Blog: